This article describes the use of 18F-fluorodeoxyglucose PET in patients who have head and neck cancer for assessment of therapy response, detection of locoregional recurrence and distant metastasis, and surveillance.
- Head and neck
- Squamous cell carcinoma
- Therapy response
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging